Phil Gutry

Insider Reports History

Location
Baltimore, MD
Signature
/s/ Zed Zduniak, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Phil Gutry:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Graphite Bio, Inc. CHIEF BUSINESS OFFICER Common Stock 300K $1.22M $4.08 11 Apr 2022 Direct
Graphite Bio, Inc. CHIEF BUSINESS OFFICER Stock Option (right to buy) 115K 16 Feb 2022 Direct
Avalo Therapeutics, Inc. Director Stock Option (Right to Buy) 4.72K 30 Sep 2021 Direct
Graphite Bio, Inc. CHIEF BUSINESS OFFICER Series B Preferred Stock 0 $5.06 29 Jun 2021 Direct

Insider Reports Filed by Phil Gutry

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GRPH Graphite Bio, Inc. 11 Apr 2022 1 $20.1K 4 CHIEF BUSINESS OFFICER 13 Apr 2022, 19:35
GRPH Graphite Bio, Inc. 16 Feb 2022 1 $0 4 CHIEF BUSINESS OFFICER 18 Feb 2022, 17:56
AVTX Avalo Therapeutics, Inc. 01 Dec 2021 0 $0 4 Director 03 Dec 2021, 19:36
AVTX Avalo Therapeutics, Inc. 30 Sep 2021 1 $0 4 Director 04 Oct 2021, 16:45
AVTX Cerecor Inc. 30 Jun 2021 1 $0 4 Director 02 Jul 2021, 16:06
GRPH Graphite Bio, Inc. 24 Jun 2021 0 $0 3 CHIEF BUSINESS OFFICER 24 Jun 2021, 21:16
AVTX Cerecor Inc. 15 Jun 2021 1 $0 4 Director 17 Jun 2021, 16:41
GRPH Graphite Bio, Inc. 13 Jan 2021 10 $148K 4 CHIEF BUSINESS OFFICER 01 Jul 2021, 19:00